Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Suzhou Basecare Medical Corp. Ltd. Class H (2170) Stock Price & Analysis

0 Followers

2170 Stock Chart & Stats

HK$1.37HK$0.01(0.37%)
At close: 4:00 PM GMT+8
HK$1.25HK$1.3HK$1.35HK$1.4Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 1.32 - HKD 1.37
52-Week Range
HKD 1.20 - HKD 2.47
Previous Close
HKD 1.37
Volume
N/A
Average Volume (3M)
37.62K
Market Cap
HKD 374.73M
Enterprise Value
HKD 345.20M
Total Cash (Recent Filing)
HKD 378.43M
Total Debt (Recent Filing)
HKD 342.35M
Price to Earnings (P/E)
―
Beta
0.55
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Solid Gross Margin

A gross margin near 48% indicates the company retains meaningful value from each product sale before operating expenses. This provides an economic base for improving profitability if revenue stabilizes and operating costs become better aligned with the company’s scale.

Moderate Leverage

Moderate leverage and a sizable equity base provide some balance-sheet support while the company invests in its medical-device business. This is more resilient than an over-levered structure and may preserve flexibility to fund operations without relying solely on additional borrowing.

Recurring Procedure-Driven Demand

Selling ART devices and consumables into IVF and fertility workflows can create recurring demand tied to procedures, especially for usage-driven products. This business model can support repeat institutional purchases and provide a more durable revenue foundation than one-time equipment sales alone.

Bears Say

Sharp Revenue Decline

The sharp 2025 revenue decline signals a material setback in commercial momentum after earlier revenue expansion. Unless growth resumes, lower scale can weaken operating leverage, reduce the company’s ability to absorb fixed costs, and delay progress toward sustainable profitability.

Deep Operating And Net Losses

Very large operating and net losses show that the current revenue base is not covering the company’s operating cost structure. Persistent unprofitability can consume equity over time, limit internally funded investment, and make a durable path to break-even dependent on substantial improvement in efficiency or sales.

Persistent Cash Burn

Negative operating and free cash flow indicate that the core business is consuming cash rather than funding itself. Continued cash burn increases dependence on external financing, which could lead to higher leverage or dilution and may constrain the company’s ability to sustain long-term product development.

Suzhou Basecare Medical Corp. Ltd. Class H News

2170 FAQ

What was Suzhou Basecare Medical Corp. Ltd. Class H’s price range in the past 12 months?
Suzhou Basecare Medical Corp. Ltd. Class H lowest stock price was HK$1.20 and its highest was HK$2.47 in the past 12 months.
What is Suzhou Basecare Medical Corp. Ltd. Class H’s market cap?
Suzhou Basecare Medical Corp. Ltd. Class H’s market cap is HK$374.73M.
When is Suzhou Basecare Medical Corp. Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Suzhou Basecare Medical Corp. Ltd. Class H’s earnings last quarter?
Suzhou Basecare Medical Corp. Ltd. Class H released its earnings results on Aug 28, 2026. The company reported -HK$0.304 earnings per share for the quarter.
Is Suzhou Basecare Medical Corp. Ltd. Class H overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Suzhou Basecare Medical Corp. Ltd. Class H pay dividends?
Suzhou Basecare Medical Corp. Ltd. Class H does not currently pay dividends.
What is Suzhou Basecare Medical Corp. Ltd. Class H’s EPS estimate?
Suzhou Basecare Medical Corp. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Suzhou Basecare Medical Corp. Ltd. Class H have?
Suzhou Basecare Medical Corp. Ltd. Class H has 82,713,840 shares outstanding.
What happened to Suzhou Basecare Medical Corp. Ltd. Class H’s price movement after its last earnings report?
Suzhou Basecare Medical Corp. Ltd. Class H reported an EPS of -HK$0.304 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Suzhou Basecare Medical Corp. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2170
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology